<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD 2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">GMS Hyg Infect Control</journal-id><journal-id journal-id-type="iso-abbrev">GMS Hyg Infect Control</journal-id><journal-id journal-id-type="publisher-id">GMS Hyg Infect Control</journal-id><journal-title-group><journal-title>GMS Hygiene and Infection Control</journal-title></journal-title-group><issn pub-type="epub">2196-5226</issn><publisher><publisher-name>German Medical Science GMS Publishing House</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4459170</article-id><article-id pub-id-type="pmid">26124985</article-id><article-id pub-id-type="publisher-id">dgkh000251</article-id><article-id pub-id-type="doi">10.3205/dgkh000251</article-id><article-id pub-id-type="publisher-id">Doc08</article-id><article-id pub-id-type="other">urn:nbn:de:0183-dgkh0002510</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>On the history of plasma treatment and comparison of microbiostatic efficacy of a historical high-frequency plasma device with two modern devices </plain></SENT>
</text></SecTag></article-title><trans-title-group xml:lang="de"><trans-title>Zur Historie der Plasmabehandlung und Vergleich der antimikrobiellen Wirkung einer historischen Hochfrequenz-Plasmaquelle mit zwei modernen Geräten</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Napp</surname><given-names>Judith</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Daeschlein</surname><given-names>Georg</given-names></name><xref ref-type="corresp" rid="COR1">*</xref><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Napp</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>von Podewils</surname><given-names>Sebastian</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gümbel</surname><given-names>Denis</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Spitzmueller</surname><given-names>Romy</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Fornaciari</surname><given-names>Paolo</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Hinz</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Jünger</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Dermatology, University Medicine, Greifswald, Germany</aff><aff id="A2"><label>2</label>Department of Trauma Surgery, University Medicine, Greifswald, Germany</aff><aff id="A3"><label>3</label>Clinic of Orthopaedic Surgery, HFR Fribourg - Hôpital cantonal, Fribourg, Switzerland</aff><author-notes><corresp id="COR1">*To whom correspondence should be addressed: Georg Daeschlein, Department of Dermatology, University Medicine Greifswald, Sauerbruchstrasse, 17475 Greifswald, Germany, Phone: +49 (0) 3834-866771, Fax: +49 (0) 3834-866772, E-mail: <email>georg.daeschlein@uni-greifswald.de</email></corresp></author-notes><pub-date pub-type="epub"><day>02</day><month>6</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>10</volume><elocation-id>Doc08</elocation-id><permissions><copyright-statement>Copyright © 2015 Napp et al.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:type="simple" xlink:href="http://www.egms.de/en/journals/dgkh/2015-10/dgkh000251.shtml">This article is available from http://www.egms.de/en/journals/dgkh/2015-10/dgkh000251.shtml</self-uri><abstract><p><SecTag type="ABS"><text><SENT sid="1" pm="."><plain>Background: Cold atmospheric pressure plasma (CAP) with its many bioactive properties has defined a new medical field: the plasma medicine. </plain></SENT>
<SENT sid="2" pm="."><plain>However, in the related form of high-frequency therapy, CAP was even used briefly a century ago. </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this study was to review historic CAP treatments and to obtain data regarding the antimicrobial efficacy of a historical high-frequency plasma device. </plain></SENT>
</text></SecTag></p><p><SecTag type="ABS"><text><SENT sid="4" pm="."><plain>Methods: First, historic literature regarding the history of CAP treatment was evaluated, because in the modern literature no data were available. </plain></SENT>
<SENT sid="5" pm="."><plain>Second, the susceptibility of 5 different bacterial wound isolates, cultured on agar, to a historic plasma source (violet wand [VW]) and two modern devices (atmospheric pressure plasma jet [APPJ] and Dielectric Barrier Discharge [DBD]) was analyzed . </plain></SENT>
<SENT sid="6" pm="."><plain>The obtained inhibition areas (IA) were compared. </plain></SENT>
</text></SecTag></p><p><SecTag type="ABS"><text><SENT sid="7" pm="."><plain>Results: First, the most convenient popular historical electromedical treatments produced a so-called effluvia by using glass electrodes, related to today’s CAP. </plain></SENT>
<SENT sid="8" pm="."><plain>Second, all three tested plasma sources showed complete eradication of all tested microbial strains in the treated area. </plain></SENT>
<SENT sid="9" pm="."><plain>The “historical” cold VW plasma showed antimicrobial effects similar to those of modern APPJ and DBD regarding the diameter of the IA. </plain></SENT>
</text></SecTag></p><p><SecTag type="ABS"><text><SENT sid="10" pm="."><plain>Conclusion: Some retrograde evidence may be deducted from this, especially for treatment of infectious diseases with historical plasma devices. </plain></SENT>
<SENT sid="11" pm="."><plain>The underlying technology may serve as model for construction of modern sucessive devices. </plain></SENT>
</text></SecTag></p></abstract><trans-abstract xml:lang="de"><title>Zusammenfassung</title><p><bold>Hintergrund:</bold> Kaltes Atmosphärendruckplasma (CAP) hat durch seine mannigfaltigen bioaktiven Eigenschaften ein neues medizinisches Feld definiert: die Plasmamedizin. Allerdings wurde vor etwa 100 Jahren CAP in verwandter Form in der Hochfrequenztherapie genutzt. Zielsetzung dieser Studie war eine Übersicht über die historischen Plasmabehandlungen zu gewinnen und Daten bezüglich der antimikrobiellen Wirkung eines historischen Hochfrequenzapparats zu gewinnen.</p><p><bold>Methode:</bold> Erstens wurde historische Literatur bezüglich CAP-Behandlungen ausgewertet, da aus dem heutigen Schrifttum keine Angaben gewonnen werden konnten. Zweitens wurde die Empfindlichkeit von fünf verschiedenen bakteriellen Wundisolaten auf Agar gegenüber einer historischen Plasmaquelle (violet wand [VW]) und zwei modernen Geräten (atmospheric pressure plasma jet [APPJ] und Dielectric Barrier Discharge [DBD]) ermittelt. Die erzielten Hemmhöfe wurde verglichen. </p><p><bold>Ergebnisse:</bold> Die seinerzeit populärsten elektromedizinischen Anwendungen erzeugten durch Glaselektroden sogenannte Effluvien, die mit modernem CAP verwandt sind. Alle drei untersuchten Plasmaquellen zeigten eine vollständige Eradikation aller behandelter Isolate im plasmabehandelten Bereich. Die historische Plasmaquelle (VW) war dabei ähnlich wirksam wie die modernen Plasmaquellen. </p><p><bold>Schlussfolgerung:</bold> In begrenztem Umfang kann retrograd ein Wirksamkeitsnachweis der historischen Plasmabehandlungen abgeleitet werden, insbesondere bei der Behandlung infektiöser Erkrankungen. Die zugrunde liegende Technologie könnte für die Entwicklung moderner Nachfolgegeräte genutzt werden. </p></trans-abstract><SecTag type="KEYWORD"><kwd-group><kwd>plasma medicine</kwd><kwd>low temperature atmospheric pressure plasma</kwd><kwd>historic plasma apparatus</kwd><kwd>antimicrobial efficacy</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="INTRO"><sec sec-type="intro"><title><text><SENT sid="12" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="13" pm="."><plain>Cold atmospheric pressure plasma (CAP) lays the foundation for the completely new medical field of plasma medicine thanks to its numerous bioactive properties [1], [2], [3]. </plain></SENT>
<SENT sid="14" pm="."><plain>At present in plasma medicine beside the two main fields of basic and applied research, the treatment of chronic wounds [4], [5], [6], [7], [8], [9], [10] and the eradication of different superficial cancer [11], the determination of the antimicrobial efficacy of CAP is an another important focus of plasma medicine [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25]. </plain></SENT>
</text></p><p><text><SENT sid="15" pm="."><plain>During the early decades of the last century, the application of high-frequency irradiation was recommended for different diseases. </plain></SENT>
<SENT sid="16" pm="."><plain>In this period many apparatus used produced spark effluvia via glass electrodes. </plain></SENT>
<SENT sid="17" pm="."><plain>This effluvia is a form of CAP, a fact mostly unknown to modern scientists in plasma medicine. </plain></SENT>
<SENT sid="18" pm="."><plain>High-frequency devices (e.g., the violet wand [VW]) were commonly sold for home-care medicine [26] until the early 1950s. </plain></SENT>
<SENT sid="19" pm="."><plain>Recently, the authors showed similar to modern plasma sources antimicrobial properties of VW generated plasma [27]. </plain></SENT>
<SENT sid="20" pm="."><plain>In short, modern CAP treatment seems a rediscovery rather than a new invention. </plain></SENT>
</text></p><p><text><SENT sid="21" pm="."><plain>First, we performed a review of historic literature regarding electro medicine, as modern literature does not exist. </plain></SENT>
<SENT sid="22" pm="."><plain>Second, we tested a historical high-frequency device (Figure 1 (Fig. 1)) for its antimicrobial efficacy and compared its results with the results of two plasma devices based on different modern technologies. </plain></SENT>
<SENT sid="23" pm="."><plain>These plasma sources have proven marked antimicrobial activity in vitro [3], [28], [29], [30], [31] including efficacy against biofilms and the literature supports many other biomedical applications [32], [33], [34], [35], [36]. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec><title><text><SENT sid="24" pm="."><plain>Overwiew of historical plasma treatment </plain></SENT>
</text></title><p><text><SENT sid="25" pm="."><plain>Electromedicine was a common medical practice in the early decades of the 20th century and efficacy was claimed for a wide spectrum of diseases. </plain></SENT>
<SENT sid="26" pm="."><plain>Arsonvalization (Figure 2 (Fig. 2)) was one of the most convenient popular electromedical treatments, classified as high-frequency therapy, and had a lot in common with modern CAP treatment, at least in terms of bioactive properties. </plain></SENT>
<SENT sid="27" pm="."><plain>This historical device produced a so-called effluvia by using glass electrodes, related to today’s CAP using glass electrodes. </plain></SENT>
<SENT sid="28" pm="."><plain>While in the first applications, pure field effects were induced from a distance, the technical development of later therapeutic devices allowed direct body and skin contact with plasma discharges. </plain></SENT>
</text></p><p><text><SENT sid="29" pm="."><plain>The French physiologist Jacques-Arsène d’Arsonval (1851–1940) [37] discovered the possibility of influencing the human body with high frequencies delivered by his apparatus with the help of extremely high transformation of electric tension. </plain></SENT>
<SENT sid="30" pm="."><plain>Technically, this had recently been made feasible by Nikola Tesla, who worked with extremely high-frequency currents at high voltage, creating impressive light phenomena which proved harmless to humans in the case of direct contact with the effusions. </plain></SENT>
</text></p><p><text><SENT sid="31" pm="."><plain>In Germany, the devices were further developed for the caloric treatment of patients (diathermy) [38]. </plain></SENT>
<SENT sid="32" pm="."><plain>Rumpf developed a device which differed from the French ones by implementing a capacitively coupled electrode consisting of a Leydener bottle which was directly applied to the patient’s skin. </plain></SENT>
<SENT sid="33" pm="."><plain>This device can be considered the first plasma source in medicine to use a dielectric electrode and can be defined as directly related to the first plasma device in chemistry, which was invented by Siemens in 1888 to produce ozone. </plain></SENT>
</text></p><p><text><SENT sid="34" pm="."><plain>The Leydener bottle used as an electrode was soon replaced by rubber (with ferrite inlay), and after industrial introduction of small hand-held devices, the waves were applied to the body and skin via vacuum, condenser, or brush electrodes producing glow discharge plasmas, brush lights, or spark effusions. </plain></SENT>
<SENT sid="35" pm="."><plain>The resulting discharge type mainly depended on voltage, the distance to the treated skin, the type of skin and soft tissue under treatment, the individual skin resistance, and the shape and construction of the chosen electrode. </plain></SENT>
<SENT sid="36" pm="."><plain>It was well known that the area of effective irradiation surpasses the visibly treated surface by far (about tenfold). </plain></SENT>
</text></p><p><text><SENT sid="37" pm="."><plain>The plasma-skin interaction was described as “electric effluvia” in the form of glow or bunch discharge, the latter creating more intense skin irritations and erythema by secondary capillary dilation, leading to decreased arterial blood pressure, among other things [39], [40]. </plain></SENT>
<SENT sid="38" pm="."><plain>Depending on the disposition of the patient, erythema lasting for hours was reported [41]. </plain></SENT>
<SENT sid="39" pm="."><plain>At the cellular level, microscopic alterations such as karyorrhexis, pyknosis, leucocytic infiltrations and cellular micro-extravasates were described. </plain></SENT>
<SENT sid="40" pm="."><plain>These effects were discussed as potential effects caused by de novo generated proteins (“protein therapy”) [41] or “anionic” effects [42]. </plain></SENT>
<SENT sid="41" pm="."><plain>The claimed efficacy of historical plasma treatments was explained by chemical, mechanical, and optical changes, i.e. the chemical ones as splitting of electrons from N and O molecules, creating new molecules such as ozone, nitric and nitrous acid, the mechanical effect as the acceleration of air molecules by ions to form “ion wind” (explained with glowing wires beginning to oscillate), and the optical plasma effects as UV radiation [26]. </plain></SENT>
</text></p><p><text><SENT sid="42" pm="."><plain>Regarding safe use, the high frequency waves were known not to interfere with motoric and sensory nervous conduction, but they do cause narcosis at high doses in animals [42]. </plain></SENT>
<SENT sid="43" pm="."><plain>Furthermore, the strong skin irritation effect was known to stimulate the respiration (increase of the respiratory volume) [43] and antimicrobial efficacy against E. coli, Salmonella typhi, C. diphtheriae, and M. tuberculosis, was shown [44]. </plain></SENT>
</text></p><sec><title><text><SENT sid="44" pm="."><plain>Practical use </plain></SENT>
</text></title><p><text><SENT sid="45" pm="."><plain>Arsonvalization was performed as local or “systemic” therapy. </plain></SENT>
<SENT sid="46" pm="."><plain>Local therapy was executed with skin electrodes, the latter indirectly with the help of large coils. </plain></SENT>
<SENT sid="47" pm="."><plain>The treatment was applied either in uni- or bipolar mode. </plain></SENT>
<SENT sid="48" pm="."><plain>The bipolar technique worked with the patient electrically connected to the grounded phase of the Tesla coil. </plain></SENT>
<SENT sid="49" pm="."><plain>In unipolar treatment, the circuit was closed via air capacity. </plain></SENT>
<SENT sid="50" pm="."><plain>A common treatment with glow discharge plasma (“effluvia therapy”) took 5–15 min. </plain></SENT>
<SENT sid="51" pm="."><plain>When spark effusion was desired for therapy, metal brushes were used. </plain></SENT>
<SENT sid="52" pm="."><plain>This treatment took 1–5 min (depending on tolerability) [26]. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="53" pm="."><plain>Technique, power, and electrodes </plain></SENT>
</text></title><p><text><SENT sid="54" pm="."><plain>The energy of arsonvalization was capacitively or inductively coupled to the body surface and tissues. </plain></SENT>
<SENT sid="55" pm="."><plain>Wave generation in the former was realized via spark gaps [26]. </plain></SENT>
</text></p><p><text><SENT sid="56" pm="."><plain>Most commonly, gas-filled vacuum electrodes were used, producing plasma glow discharges and creating vacuum discharges of different colors according to the gas employed [26]. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="57" pm="."><plain>Medical indications and practice </plain></SENT>
</text></title><p><text><SENT sid="58" pm="."><plain>Typical recommended indications were lichen ruber, cervical catarrh, arterial hypertension, eczema, pruritus, migraines/neuralgia, infectious diseases of the skin, and wounds [26], [38], [44], [45], [46], [47], [48], [49], [50]. </plain></SENT>
<SENT sid="59" pm="."><plain>Another indication in dermatology was the treatment of hemorrhoids, skin tumors (carcinomata), viral warts, furuncles and abcesses [26], [50], [51], [52]. </plain></SENT>
<SENT sid="60" pm="."><plain>Healing effects on tuberculosis were claimed repeatedly [50], [53], [54]. </plain></SENT>
<SENT sid="61" pm="."><plain>In dentistry, Henseler [55] described many procedures and indications including anesthesia before tooth extraction, but also antiseptic treatments and treatment of abcesses, stomatitis, and hyperesthesia. </plain></SENT>
<SENT sid="62" pm="."><plain>Tooth bleaching, gingival and pulpa anesthesia were also common [55]. </plain></SENT>
<SENT sid="63" pm="."><plain>Further treatments in dermatology were iontopheresis and the improvement of topical drug penetration [56] which is a promising perspective for modern plasma sources [57], [58], [59], [60], [61], [62]. </plain></SENT>
<SENT sid="64" pm="."><plain>In neurology, the most common indications were neurotic disorders, migraines, and neuronal pain syndromes; the effects were in part explained by functional neurophysiology but also by suggestive effects [46]. </plain></SENT>
</text></p></sec></sec></SecTag><sec><title><text><SENT sid="65" pm="."><plain>Comparison of microbiostatic efficacy of a historical high-frequency plasma device with two modern devices in vitro </plain></SENT>
</text></title><sec><title><text><SENT sid="66" pm="."><plain>Method </plain></SENT>
</text></title><p><text><SENT sid="67" pm="."><plain>The in vitro model for plasma susceptibility testing was performed as previously described [3]. </plain></SENT>
<SENT sid="68" pm="."><plain>Three plasma sources in different modes or with different electrodes were used. </plain></SENT>
<SENT sid="69" pm="."><plain>First, the APPJ (INP, Greifswald, Germany) was applied in three modes, one pulsed (A) and two non-pulsed (B, C). </plain></SENT>
<SENT sid="70" pm="."><plain>For a detailed description, see [31], [57]. </plain></SENT>
<SENT sid="71" pm="."><plain>Second, a Dielectric Barrier Discharge (DBD) plasma device (CINOGY, Duderstadt, Germany) was used with two dielectric barrier electrodes differing in size (20 mm diameter electrode A, 4 mm diameter electrode B). </plain></SENT>
<SENT sid="72" pm="."><plain>For a detailed technical description, see [58], [59]. </plain></SENT>
<SENT sid="73" pm="."><plain>Third, the historical CAP device, model 0126, 2 pol. constructed 1950 (Tefra, Berlin, Germany) (Figure 1 (Fig. 1)) was used. </plain></SENT>
<SENT sid="74" pm="."><plain>For efficacy testing we followed the settings in our previous publication [27]. </plain></SENT>
</text></p><p><text><SENT sid="75" pm="."><plain>All pathogens used (Staphylococcus epidermidis [SE], Staphylococcus aureus [SA], Candida albicans [CA], Escherichia coli [EC], and Pseudomonas aeruginosa [PA]) were clinically wound isolates. </plain></SENT>
<SENT sid="76" pm="."><plain>The test strains were exposed by CAP for 0, 3, 9, 15, 30, 60, and 90 s using six plasma sources/modes (DBD A, DBD B, APPJ A, APPJ B, APPJ C, and the VW) on Columbia blood agar (Biomérieux, Nürtingen, Germany). </plain></SENT>
</text></p><p><text><SENT sid="77" pm="."><plain>The diameters of the obtained inhibition areas (IA) were measured (mean of two measurements at perpendicular to each other) to calculate the susceptibility of isolates. </plain></SENT>
<SENT sid="78" pm="."><plain>The results give an overview of the dose response kinetics. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="79" pm="."><plain>Results </plain></SENT>
</text></title><p><text><SENT sid="80" pm="."><plain>The high-frequency generated plasma by the VW showed similar activity against SE, SA, CA, EC, and PA throughout the entire test phase between 3 and 90 s (Figure 3a–e (Fig. 3)). </plain></SENT>
<SENT sid="81" pm="."><plain>The largest diameters were recorded after DBD with the large electrode; all other treatments were similar except VW plasma (large electrode), which produced a greater diameter compared to all other treatments except DBD (large electrode), when MSSA, SE, and EC were tested (Fig. 3b, c, and e (Fig. 3)). </plain></SENT>
<SENT sid="82" pm="."><plain>When CA (Fig. 3a (Fig. 3)) was tested, the diameters obtained with DBD with the small electrode were markedly lower than those of all the other sources. </plain></SENT>
</text></p></sec></sec><SecTag type="DISCUSS"><sec sec-type="discussion"><title><text><SENT sid="83" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="84" pm="."><plain>Many of the historical descriptions and claimed clinical applications are not plausible according to the standard of evidence-based medicine and systematic revision of the stated explanations is needed. </plain></SENT>
<SENT sid="85" pm="."><plain>However, it is possible that patients benefitted from these treatments performed in millions [63], whatever the underlying active principle may have been. </plain></SENT>
</text></p><p><text><SENT sid="86" pm="."><plain>Because of the known efficacy of modern CAP, we proposed the hypothesis of similar effects by effluvia plasma discharges. </plain></SENT>
<SENT sid="87" pm="."><plain>To address this question, we tested basic antimicrobial properties of a representative “historical” device compared to two modern plasma sources, and can state that at least some potential beneficial clinical effect may not be purely psychosomatic. </plain></SENT>
<SENT sid="88" pm="."><plain>Our tests clearly demonstrated marked antimicrobial activity against all tested species in vitro. </plain></SENT>
<SENT sid="89" pm="."><plain>The effects of VW were not significantly different from those of the modern plasma devices. </plain></SENT>
<SENT sid="90" pm="."><plain>Thus, it is reasonable to propose a clinically relevant antibacterial effect of the VW when infected or contaminated skin was irradiated with VW plasma. </plain></SENT>
</text></p><p><text><SENT sid="91" pm="."><plain>The authors already demonstrated the in-vitro efficacy of modern CAP and historic VW generated plasma against many different wound pathogens [27], [64]. </plain></SENT>
<SENT sid="92" pm="."><plain>Similar data were obtained with another modern plasma source based on different technology [65]. </plain></SENT>
<SENT sid="93" pm="."><plain>Apart from in-vitro data, clinical studies on CAP treatment have been recently published supporting relevant efficacy against multidrug-resistant bacteria [12], [13], [14], [66]. </plain></SENT>
<SENT sid="94" pm="."><plain>As a result of its proven antimicrobial efficacy, CAP is currently being examined for treatment of chronic wounds [12], [67], [68] and may also be effective in hospital hygiene [67], [68], [69]. </plain></SENT>
<SENT sid="95" pm="."><plain>Accordingly, stimulation of wound healing supported by antiseptic activity may also be obtained with the historical VW plasma or, rather, with re-invented devices based on electromechanical techniques. </plain></SENT>
</text></p></sec></SecTag><SecTag type="CONCL"><sec sec-type="conclusions"><title><text><SENT sid="96" pm="."><plain>Conclusions </plain></SENT>
</text></title><p><text><SENT sid="97" pm="."><plain>Our data demonstrate in vitro antimicrobial efficacy of a historical CAP device and some retrograde evidence may be deducted from this, especially for different diseases that may have benefitted from antimicrobial activity. </plain></SENT>
</text></p></sec></SecTag><sec><title><text><SENT sid="98" pm="."><plain>Notes </plain></SENT>
</text></title><sec><title><text><SENT sid="99" pm="."><plain>Competing interests </plain></SENT>
</text></title><p><text><SENT sid="100" pm="."><plain>The authors declare that they have no competing interests. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="101" pm="."><plain>Authorship </plain></SENT>
</text></title><p><text><SENT sid="102" pm="."><plain>The authors Napp J and Daeschlein G contributed equally. </plain></SENT>
</text></p></sec></sec></body><back><SecTag type="REF"><ref-list><ref id="R1"><text><SENT sid="103" pm="."><plain>1 BrandenburgREhlbeckJStieberM Antimicrobial treatment of heat sensitive materials by means of atmospheric pressure rf-driven plasma jet Contrib Plasma Phys 2007 47 1-2 72 79 10.1002/ctpp.200710011 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ctpp.200710011">http://dx.doi.org/10.1002/ctpp.200710011</ext-link>  </plain></SENT>
</text></ref><ref id="R2"><text><SENT sid="104" pm="."><plain>2 FridmanGBrooksADBalasubramanianMFridmanAGutsolAVasiletsVNAyanHFriedmanG Comparison of direct and indirect effect of non thermal atmpospheric pressure plasma on bacteria Plasma Process Polym 2007 4 4 370 375 10.1002/ppap.200600217 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ppap.200600217">http://dx.doi.org/10.1002/ppap.200600217</ext-link>  </plain></SENT>
</text></ref><ref id="R3"><text><SENT sid="105" pm="."><plain>3 DaeschleinGvon WoedtkeTKindelEBrandenburgRWeltmannKDJüngerM Antibacterial activity of an atmospheric pressure plasma jet against relevant wound pathogens in-vitro on a simulated wound environment Plasma Process Polym 2010 7 3-4 224 230 10.1002/ppap.200900059 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ppap.200900059">http://dx.doi.org/10.1002/ppap.200900059</ext-link>  </plain></SENT>
</text></ref><ref id="R4"><text><SENT sid="106" pm="."><plain>4 KramerAHübnerNOWeltmannKDLademannJEkkernkampAHinzPAssadianO Polypragmasia in the therapy of infected wounds – conclusions drawn from the perspectives of low temperature plasma technology for plasma wound therapy GMS Krankenhaushyg Interdiszip 2008 3 1 Doc13 Available from: <ext-link ext-link-type="uri" xlink:href="http://www.egms.de/en/journals/dgkh/2008-3/dgkh000111.shtml">http://www.egms.de/en/journals/dgkh/2008-3/dgkh000111.shtml</ext-link>  </plain></SENT>
</text></ref><ref id="R5"><text><SENT sid="107" pm="."><plain>5 KramerAHübnerNOAssadianOBelowHBenderCBenkhaiH Chancen und Perspektiven der Plasmamedizin durch Anwendung von gewebekompatiblen Atmosphärendruckplasmen (Tissue Tolerable Plasmas, TTP) Chances and perspectives of the plasma medicine by use of Tissue Tolerable Plasma (TTP) GMS Krankenhaushyg Interdiszip 2009 4 2 Doc10 10.3205/dgkh000135 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3205/dgkh000135">http://dx.doi.org/10.3205/dgkh000135</ext-link>  </plain></SENT>
</text></ref><ref id="R6"><text><SENT sid="108" pm="."><plain>6 BenderCParteckeLIKindelEDöringFLademannJHeideckeCDKramerAHübnerNO The modified HET-CAM as a model for the assessment of the inflammatory response to tissue tolerable plasma Toxicol In Vitro 3 2011 25 2 530 537 10.1016/j.tiv.2010.11.012 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.tiv.2010.11.012">http://dx.doi.org/10.1016/j.tiv.2010.11.012</ext-link> 21111803 </plain></SENT>
</text></ref><ref id="R7"><text><SENT sid="109" pm="?"><plain>7 BenderCHübnerNOWeltmannKDScharfCKramerA MachalaZHendselKAkishevY Tissue tolerable plasma and polihexanide: Are synergistic effects possible to promote healing of chronic wounds? </plain></SENT>
<SENT sid="110" pm="."><plain>In vivo and in vitro results Plasma for Bio-Decontamination, Medicine and Food Security; NATO Science for Peace and Security 2012 Dordrecht (Netherlands) Springer 321 334 10.1007/978-94-007-2852-3_25 Series A: Chemistry and Biology Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/978-94-007-2852-3_25">http://dx.doi.org/10.1007/978-94-007-2852-3_25</ext-link>  </plain></SENT>
</text></ref><ref id="R8"><text><SENT sid="111" pm="."><plain>8 KramerAAssadianOBelowHWillyC WillyC Wound antiseptics today – an overview Antiseptics in surgery – update 2013 2013 Berlin Lindqvist 85 111  </plain></SENT>
</text></ref><ref id="R9"><text><SENT sid="112" pm="."><plain>9 KramerALademannJBenderCSckellAHartmannBMünchSHinzetPal Suitability of Tissue Tolerable Plasmas (TTP) for the management of chronic wounds Clin Plasma Med 2013 1 1 11 18 10.1016/j.cpme.2013.03.002 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cpme.2013.03.002">http://dx.doi.org/10.1016/j.cpme.2013.03.002</ext-link>  </plain></SENT>
</text></ref><ref id="R10"><text><SENT sid="113" pm="."><plain>10 UlrichCKluschkeFPatzeltA Exploratory research study to investigate the clinical use of cold atmospheric pressure argon plasma in the treatment of chronic wounds - a pilot study using a novel plasma jet prototype. J Wound Care accepted  </plain></SENT>
</text></ref><ref id="R11"><text><SENT sid="114" pm="."><plain>11 ParteckeLIEvertKHaugkJDoeringFNormannLDiedrichSWeissFUEvertMHuebnerNOGuentherCHeideckeCDKramerABussiahnRWeltmannKDPatiOBenderCvon BernstorffW Tissue tolerable plasma (TTP) induces apoptosis in pancreatic cancer cells in vitro and in vivo BMC Cancer 15 10 2012 12 473 10.1186/1471-2407-12-473 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2407-12-473">http://dx.doi.org/10.1186/1471-2407-12-473</ext-link> 23066891 </plain></SENT>
</text></ref><ref id="R12"><text><SENT sid="115" pm="."><plain>12 BrehmerFHaenssleHADaeschleinGAhmedRPfeifferSGörlitzA Alleviation of chronic venous leg ulcers with a hand-held dielectric barrier discharge plasma generator (PlasmaDerm® VU-2010): Results of a monocentric, two-armed, open, prospective, randomized, and controlled trial (NCT01415622) J Eur Acad Dermatol Venereol 2014 29 1 148 155 10.1111/jdv.12490 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/jdv.12490">http://dx.doi.org/10.1111/jdv.12490</ext-link> 24666170 </plain></SENT>
</text></ref><ref id="R13"><text><SENT sid="116" pm="."><plain>13 IsbaryGMorfillGSchmidtHUGeorgiMRamrathKHeinlinJKarrerSLandthalerMShimizuTSteffesBBunkWMonettiRZimmermannJLPomplRStolzW A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients Br J Dermatol 7 2010 163 1 78 82 10.1111/j.1365-2133.2010.09744.x Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1365-2133.2010.09744.x">http://dx.doi.org/10.1111/j.1365-2133.2010.09744.x</ext-link> 20222930 </plain></SENT>
</text></ref><ref id="R14"><text><SENT sid="117" pm="."><plain>14 IsbaryGHeinlinJShimizuTZimmermannJLMorfillGSchmidtHUMonettiRSteffesBBunkWLiYKlaempflTKarrerSLandthalerMStolzW Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial Br J Dermatol 8 2012 167 2 404 410 10.1111/j.1365-2133.2012.10923.x Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1365-2133.2012.10923.x">http://dx.doi.org/10.1111/j.1365-2133.2012.10923.x</ext-link> 22385038 </plain></SENT>
</text></ref><ref id="R15"><text><SENT sid="118" pm="."><plain>15 LademannOKramerARichterHPatzeltAMeinkeMCCzaikaVWeltmannKDHartmannBKochS Skin disinfection by plasma-tissue interaction: comparison of the effectivity of tissue-tolerable plasma and a standard antiseptic Skin Pharmacol Physiol 2011 24 5 284 288 10.1159/000329913 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1159/000329913">http://dx.doi.org/10.1159/000329913</ext-link> 21709431 </plain></SENT>
</text></ref><ref id="R16"><text><SENT sid="119" pm="."><plain>16 LademannOKramerARichterHPatzeltAMeinkeMCRoewert-HuberJ Antisepsis of the follicular reservoir by treatment with tissue-tolerable plasma (TTP) Laser Phys Lett 2011 8 4 313 317 10.1002/lapl.201010123 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/lapl.201010123">http://dx.doi.org/10.1002/lapl.201010123</ext-link>  </plain></SENT>
</text></ref><ref id="R17"><text><SENT sid="120" pm="."><plain>17 FrickeKKobanITrespHJablonowskiLSchröderKKramerAWeltmannKDvon WoedtkeTKocherT Atmospheric pressure plasma: a high-performance tool for the efficient removal of biofilms PLoS ONE 2012 7 8 e42539 10.1371/journal.pone.0042539 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0042539">http://dx.doi.org/10.1371/journal.pone.0042539</ext-link> 22880025 </plain></SENT>
</text></ref><ref id="R18"><text><SENT sid="121" pm="."><plain>18 LademannJRichterHSchanzerSPatzeltAThiedeGKramerAWeltmannKDHartmannBLange-AsschenfeldtB Comparison of the antiseptic efficacy of tissue-tolerable plasma and an octenidine hydrochloride-based wound antiseptic on human skin Skin Pharmacol Physiol 2012 25 2 100 106 10.1159/000335558 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1159/000335558">http://dx.doi.org/10.1159/000335558</ext-link> 22301799 </plain></SENT>
</text></ref><ref id="R19"><text><SENT sid="122" pm="."><plain>19 KobanIGeiselMHHoltfreterBJablonowskiLHübnerNOMatthesRMasurKWeltmannKDKramerAKocherT Synergistic Effects of Nonthermal Plasma and Disinfecting Agents against Dental Biofilms In Vitro ISRN Dent 12 9 2013 2013 573262 10.1155/2013/573262 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1155/2013/573262">http://dx.doi.org/10.1155/2013/573262</ext-link> 24159388 </plain></SENT>
</text></ref><ref id="R20"><text><SENT sid="123" pm="."><plain>20 MatthesRBenderCSchlüterRKobanIBussiahnRReuterSLademannJWeltmannKDKramerA Antimicrobial efficacy of two surface barrier discharges with air plasma against in vitro biofilms PLoS ONE 2013 8 7 e70462 10.1371/journal.pone.0070462 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0070462">http://dx.doi.org/10.1371/journal.pone.0070462</ext-link> 23894661 </plain></SENT>
</text></ref><ref id="R21"><text><SENT sid="124" pm="."><plain>21 MatthesRKobanIBenderCMasurKKindelEWeltmannKD Antimicrobial efficacy of an atmospheric pressure plasma jet against biofilms of Pseudomonas aeruginosa and Staphylococcus epidermidis Plasma Proc Polym 2013 10 2 161 166 10.1002/ppap.201100133 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ppap.201100133">http://dx.doi.org/10.1002/ppap.201100133</ext-link>  </plain></SENT>
</text></ref><ref id="R22"><text><SENT sid="125" pm="."><plain>22 KlebesMUlrichCKluschkeFPatzeltAVanderseeSRichterHBobAvon HuttenJKredietJTKramerALademannJLange-AsschenfeldB Combined antibacterial effects of tissue-tolerable plasma and a modern conventional liquid antiseptic on chronic wound treatment J Biophotonics 5 2015 8 5 382 391 10.1002/jbio.201400007 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/jbio.201400007">http://dx.doi.org/10.1002/jbio.201400007</ext-link> 24659472 </plain></SENT>
</text></ref><ref id="R23"><text><SENT sid="126" pm="."><plain>23 MatthesRAssadianOKramerA Repeated applications of cold atmospheric pressure plasma does not induce resistance in Staphylococcus aureus embedded in biofilms GMS Hyg Infect Control 2014 9 3 Doc17 10.3205/dgkh000237 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3205/dgkh000237">http://dx.doi.org/10.3205/dgkh000237</ext-link> 25285261 </plain></SENT>
</text></ref><ref id="R24"><text><SENT sid="127" pm="."><plain>24 MatthesRLührmannAHoltfreterS Antibacterial activity of cold atmospheric pressure argon plasma against 78 genetically different (mecA, luk-P, agr or capsular polysaccharide type) Staphylococcus aureus strains Skin pharmacol physiol 2015 accepted  </plain></SENT>
</text></ref><ref id="R25"><text><SENT sid="128" pm="."><plain>25 MatthesRJablonowskiLKobanIQuadeAHübnerNOSchlueterRWeltmannKDvon WoedtkeTKramerAKocherT In vitro treatment of Candida albicans biofilms on denture base material with volume dielectric barrier discharge plasma (VDBD) compared with common chemical antiseptics Clin Oral Investig 22 4 2015 10.1007/s00784-015-1463-y Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00784-015-1463-y">http://dx.doi.org/10.1007/s00784-015-1463-y</ext-link>  </plain></SENT>
</text></ref><ref id="R26"><text><SENT sid="129" pm="."><plain>26 SchneeA Kompendium der Hochfrequenz in ihren verschiedenen Anwendungsformen einschliesslich der Diathermie 1920 Leipzig Otto Nemnich  </plain></SENT>
</text></ref><ref id="R27"><text><SENT sid="130" pm="."><plain>27 DaeschleinGNappMvon PodewilsSScholzSArnoldAEmmertSHaaseHNappJSpitzmuellerRGümbelDJüngerM Antimicrobial Efficacy of a Historical High-Frequency Plasma Apparatus in Comparison With 2 Modern, Cold Atmospheric Pressure Plasma Devices Surg Innov 9 3 2015 10.1177/1553350615573584 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/1553350615573584">http://dx.doi.org/10.1177/1553350615573584</ext-link>  </plain></SENT>
</text></ref><ref id="R28"><text><SENT sid="131" pm="."><plain>28 DaeschleinGScholzSArnoldAvon WoedtkeTKindelENiggemeierMWeltmannKDJüngerM In-vitro activity of atmospheric pressure plasma jet (APPJ) against clinical isolates of Demodex folliculorum IEEE Trans Plasma Sci 2010 38 10 2969 2973 10.1109/TPS.2010.2061870 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1109/TPS.2010.2061870">http://dx.doi.org/10.1109/TPS.2010.2061870</ext-link>  </plain></SENT>
</text></ref><ref id="R29"><text><SENT sid="132" pm="."><plain>29 DaeschleinGScholzSvon WoedtkeTNiggemeierMKindelEBrandenburgRWeltmannKDJüngerM In-vitro killing of clinical fungal strains by low temperature atmospheric pressure plasma (APPJ) IEEE Trans Plasma Sci 2011 39 11 815 821 10.1109/TPS.2010.2063441 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1109/TPS.2010.2063441">http://dx.doi.org/10.1109/TPS.2010.2063441</ext-link>  </plain></SENT>
</text></ref><ref id="R30"><text><SENT sid="133" pm="."><plain>30 DaeschleinGScholzSArnoldAvon PodewilsSHaaseHEmmertSteffen In-vitro susceptibility of important skin and wound pathogens against low temperature atmospheric pressure plasma jet (APPJ) and dielectric barrier discharge plasma (DBD) Plasma Process Polym 2012 9 4 380 389 10.1002/ppap.201100160 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ppap.201100160">http://dx.doi.org/10.1002/ppap.201100160</ext-link>  </plain></SENT>
</text></ref><ref id="R31"><text><SENT sid="134" pm="."><plain>31 DaeschleinGScholzSAhmedRMajumdarAvon WoedtkeTHaaseHNiggemeierMKindelEBrandenburgRWeltmannKDJüngerM Cold plasma is well-tolerated and does not disturb skin barrier or reduce skin moisture J Dtsch Dermatol Ges 7 2012 10 7 509 515 10.1111/j.1610-0387.2012.07857.x Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1610-0387.2012.07857.x">http://dx.doi.org/10.1111/j.1610-0387.2012.07857.x</ext-link> 22405534 </plain></SENT>
</text></ref><ref id="R32"><text><SENT sid="135" pm="."><plain>32 FridmanGFriedmanGGutsolAShekhterABVasiletsVNFridmanA Applied plasma medicine Plasma Process Polym 2008 5 6 503 533 10.1002/ppap.200700154 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ppap.200700154">http://dx.doi.org/10.1002/ppap.200700154</ext-link>  </plain></SENT>
</text></ref><ref id="R33"><text><SENT sid="136" pm="."><plain>33 LaroussiM The biomedical applications of plasma: A brief history of the development of a new field of research IEEE Trans Plasma Sci 2008 36 4 1612 1614 10.1109/TPS.2008.917167 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1109/TPS.2008.917167">http://dx.doi.org/10.1109/TPS.2008.917167</ext-link>  </plain></SENT>
</text></ref><ref id="R34"><text><SENT sid="137" pm="."><plain>34 ChoiJMohamedAAHKangSKWooKCKimKTLeeJK 900-MHz Nonthermal atmospheric pressure plasma jet for biomedical applications Plasma Proc Polym 2010 7 3-4 258 263 10.1002/ppap.200900079 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ppap.200900079">http://dx.doi.org/10.1002/ppap.200900079</ext-link>  </plain></SENT>
</text></ref><ref id="R35"><text><SENT sid="138" pm="."><plain>35 YousfiMBeksteinAMerbahiNEichwaldODucasseOBenhenniMGardouJP Basic data for atmospheric pressure non-thermal plasma investigations in environmental and biomedical applications Plasma Sources Sci Technol 2010 19 3 034004 10.1088/0963-0252/19/3/034004 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1088/0963-0252/19/3/034004">http://dx.doi.org/10.1088/0963-0252/19/3/034004</ext-link>  </plain></SENT>
</text></ref><ref id="R36"><text><SENT sid="139" pm="."><plain>36 WeltmannKDvon WoedtkeTBrandenburgREhlbeckJ Biomedical applications of atmospheric pressure plasma Chem Listy 2008 102 s1450 s1451 Available from: <ext-link ext-link-type="uri" xlink:href="http://www.chemicke-listy.cz/common/article-vol_102-issue_s4-page_s1450.html">http://www.chemicke-listy.cz/common/article-vol_102-issue_s4-page_s1450.html</ext-link>  </plain></SENT>
</text></ref><ref id="R37"><text><SENT sid="140" pm="."><plain>37 d´ArsonvalJ Nouvel appareil de diathermie intensive Arch Électricité Médic 1914 377  </plain></SENT>
</text></ref><ref id="R38"><text><SENT sid="141" pm="."><plain>38 NagelschmidtCF Über Hochfrequenzströme. </plain></SENT>
<SENT sid="142" pm="."><plain>Berl. med. </plain></SENT>
<SENT sid="143" pm="."><plain>Ges. </plain></SENT>
<SENT sid="144" pm="."><plain>24. </plain></SENT>
<SENT sid="145" pm="."><plain>02 1909 Berl Klin Wschr 10 1909  </plain></SENT>
</text></ref><ref id="R39"><text><SENT sid="146" pm="."><plain>39 BühlerA Erfolge der Hochfrequenzströme bei Arteriosklerose Med Klinik 1914 2 55 57  </plain></SENT>
</text></ref><ref id="R40"><text><SENT sid="147" pm="."><plain>40 BraunwarthFischer Über den Einfluss der verschiedenen Arten der Hochfrequenz-Behandlung auf das cardiovaskuläre System Med Klin 1913 3  </plain></SENT>
</text></ref><ref id="R41"><text><SENT sid="148" pm="."><plain>41 Von WendtGZeileisFG Beobachtungen über die physiologische Einwirkung unipolarer hochfrequenter elektrischer Entladungen in Verbindung mit Radiumstrahlung 1929 München Süddeutsches Verlagsinstitut Julius Müller  </plain></SENT>
</text></ref><ref id="R42"><text><SENT sid="149" pm="."><plain>42 SteffensP Therap. </plain></SENT>
<SENT sid="150" pm="."><plain>Monatshefte Z Gesamte Physikalische Therapie 1913 30 5  </plain></SENT>
</text></ref><ref id="R43"><text><SENT sid="151" pm="."><plain>43 GrableyP Hochfrequenzbehandlung bei nervösen und organischen Herzstörungen Med Klin 1912 25  </plain></SENT>
</text></ref><ref id="R44"><text><SENT sid="152" pm="."><plain>44 LaqueurA Die Behandlung mit Hochfrequenzströmen Med Klin 1911  </plain></SENT>
</text></ref><ref id="R45"><text><SENT sid="153" pm="."><plain>45 LaqueurA Die therapeutische Anwendung der Hochfrequenzströme Therapie Gegenw 1911 1  </plain></SENT>
</text></ref><ref id="R46"><text><SENT sid="154" pm="."><plain>46 Mann Die elektrische Behandlung der Neuralgien Z Physik Diät Ther 1913 9  </plain></SENT>
</text></ref><ref id="R47"><text><SENT sid="155" pm="."><plain>47 KrausF Leitfaden der Elektrotherapie 1928 Wien, Berlin Julius Springer  </plain></SENT>
</text></ref><ref id="R48"><text><SENT sid="156" pm="."><plain>48 KahaneM Über die Hochfrequenzströme und ihre Indikationen Z Physik Diät Ther 1911 9 12  </plain></SENT>
</text></ref><ref id="R49"><text><SENT sid="157" pm="."><plain>49 BaedekerK Die Arsonvalisation Wien Klin 1901 10/11  </plain></SENT>
</text></ref><ref id="R50"><text><SENT sid="158" pm="."><plain>50 RiviéreC Die Elektrotherapie in der Behandlung der Tuberkulose Zbl Inn Med 1909 45  </plain></SENT>
</text></ref><ref id="R51"><text><SENT sid="159" pm="."><plain>51 VogelC Behandlung der Hämorrhoiden mit hochfrequenten Strahlen Med Welt 1928 7  </plain></SENT>
</text></ref><ref id="R52"><text><SENT sid="160" pm="."><plain>52 De Keating-HartWV Fulguration et Cancer Jahrbuch über Leistungen und Fortschritte auf dem Gebiet der physikalischen Medizin. 1920 II. </plain></SENT>
<SENT sid="161" pm="."><plain>Bd. Leipzig, München Otto Neumeier  </plain></SENT>
</text></ref><ref id="R53"><text><SENT sid="162" pm="."><plain>53 DoumerH Über die Behandlung der tuberkulösen Ostitis mit Hochfrequenzströmen Acad Sci 1 4 1912  </plain></SENT>
</text></ref><ref id="R54"><text><SENT sid="163" pm="."><plain>54 Massimi L´azione della corrente elettrica altermata di alta frequenzia sui node linfantici tubercolari Tuberculosi 1928 20 477 489  </plain></SENT>
</text></ref><ref id="R55"><text><SENT sid="164" pm="."><plain>55 HenselerH Die Hochfrequenzbehandlung mit Hochleistungs-Apparaten in der ärztlichen Praxis 1930 Berlin Radionta  </plain></SENT>
</text></ref><ref id="R56"><text><SENT sid="165" pm="."><plain>56 RumpfT Die Anwendung der oszillierenden Ströme 1927 Jena Fischer  </plain></SENT>
</text></ref><ref id="R57"><text><SENT sid="166" pm="."><plain>57 WeltmannKDKindelEBrandenburgRMeyerCBussiahnRWilkeCvon WoedtkeT Atmospheric pressure plasma jet for medical therapy: Plasma parameters and risk estimation Contrib Plasma Phys 2009 49 9 631 640 10.1002/ctpp.200910067 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ctpp.200910067">http://dx.doi.org/10.1002/ctpp.200910067</ext-link>  </plain></SENT>
</text></ref><ref id="R58"><text><SENT sid="167" pm="."><plain>58 KuchenbeckerMBibinovNKaemlingAWandkeDAwakowiczPViölW Characterization of DBD plasma source for biomedical applications J Phys D Appl Phys 2009 42 4 045212 10.1088/0022-3727/42/4/045212 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1088/0022-3727/42/4/045212">http://dx.doi.org/10.1088/0022-3727/42/4/045212</ext-link>  </plain></SENT>
</text></ref><ref id="R59"><text><SENT sid="168" pm="."><plain>59 HelmkeAHoffmeisterDMertensNEmmertSSchuette1JVioelW The acidification of lipid film surfaces by non-thermal DBD at atmospheric pressure in air New J Phys 2009 11 115025 10.1088/1367-2630/11/11/115025 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1088/1367-2630/11/11/115025">http://dx.doi.org/10.1088/1367-2630/11/11/115025</ext-link>  </plain></SENT>
</text></ref><ref id="R60"><text><SENT sid="169" pm="."><plain>60 LademannORichterHKramerAPatzeltAMeinkeMCGrafC Stimulation of the penetration of particles into the skin by plasma tissue interaction Laser Phys Lett 2011 8 10 758 764 10.1002/lapl.201110055 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/lapl.201110055">http://dx.doi.org/10.1002/lapl.201110055</ext-link>  </plain></SENT>
</text></ref><ref id="R61"><text><SENT sid="170" pm="."><plain>61 LademannORichterHMeinkeMCPatzeltAKramerAHinzPWeltmannKDHartmannBKochS Drug delivery through the skin barrier enhanced by treatment with tissue-tolerable plasma Exp Dermatol 6 2011 20 6 488 490 10.1111/j.1600-0625.2010.01245.x Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1600-0625.2010.01245.x">http://dx.doi.org/10.1111/j.1600-0625.2010.01245.x</ext-link> 21371126 </plain></SENT>
</text></ref><ref id="R62"><text><SENT sid="171" pm="."><plain>62 LademannJPatzeltARichterHLademannOBaierGBreuckerLLandfesterK Nanocapsules for drug delivery through the skin barrier by tissue-tolerable plasma Laser Phys Lett 2013 10 8 83001 10.1088/1612-2011/10/8/083001 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1088/1612-2011/10/8/083001">http://dx.doi.org/10.1088/1612-2011/10/8/083001</ext-link>  </plain></SENT>
</text></ref><ref id="R63"><text><SENT sid="172" pm="."><plain>63 TreibmannE Ergebnisse der Hochfrequenzbehandlung Dtsch med Wochenschr 1927 53 51 2168 2170 10.1055/s-0028-1127093 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1055/s-0028-1127093">http://dx.doi.org/10.1055/s-0028-1127093</ext-link>  </plain></SENT>
</text></ref><ref id="R64"><text><SENT sid="173" pm="."><plain>64 DaeschleinGNappMvon PodewilsSLutzeSEmmertSLangeA In-vitro susceptibility of multidrug resistant skin and wound pathogens against low temperature atmospheric pressure plasma jet (APPJ) and dielectric barrier discharge plasma (DBD) Plasma Process Polym 2014 11 2 175 183 10.1002/ppap.201300070 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ppap.201300070">http://dx.doi.org/10.1002/ppap.201300070</ext-link>  </plain></SENT>
</text></ref><ref id="R65"><text><SENT sid="174" pm="."><plain>65 MorfillGEShimizuTSteffesBSchmidtHU Nosocomial infections-a new approach towards preventive medicine using plasmas New J Phys 2009 11 115019 10.1088/1367-2630/11/11/115019 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1088/1367-2630/11/11/115019">http://dx.doi.org/10.1088/1367-2630/11/11/115019</ext-link>  </plain></SENT>
</text></ref><ref id="R66"><text><SENT sid="175" pm="."><plain>66 DaeschleinGNappMLutzeSArnoldAvon PodewilsSGuembelDJüngerM Skin and wound decontamination of multidrug-resistant bacteria by cold atmospheric plasma coagulation J Dtsch Dermatol Ges 2 2015 13 2 143 150 10.1111/ddg.12559 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/ddg.12559">http://dx.doi.org/10.1111/ddg.12559</ext-link> 25597338 </plain></SENT>
</text></ref><ref id="R67"><text><SENT sid="176" pm="."><plain>67 O'ConnorNCahillODanielsSGalvinSHumphreysH Cold atmospheric pressure plasma and decontamination. </plain></SENT>
<SENT sid="177" pm="."><plain>Can it contribute to preventing hospital-acquired infections? J Hosp Infect 10 2014 88 2 59 65 10.1016/j.jhin.2014.06.015 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jhin.2014.06.015">http://dx.doi.org/10.1016/j.jhin.2014.06.015</ext-link> 25146226 </plain></SENT>
</text></ref><ref id="R68"><text><SENT sid="178" pm="."><plain>68 Mai-ProchnowAMurphyABMcLeanKMKongMGOstrikovKK Atmospheric pressure plasmas: infection control and bacterial responses Int J Antimicrob Agents 6 2014 43 6 508 517 10.1016/j.ijantimicag.2014.01.025 Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijantimicag.2014.01.025">http://dx.doi.org/10.1016/j.ijantimicag.2014.01.025</ext-link> 24637224 </plain></SENT>
</text></ref><ref id="R69"><text><SENT sid="179" pm="."><plain>69 HeinlinJMorfillGLandthalerMStolzWIsbaryGZimmermannJLShimizuTKarrerS Plasma medicine: possible applications in dermatology J Dtsch Dermatol Ges 12 2010 8 12 968 976 10.1111/j.1610-0387.2010.07495.x Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1610-0387.2010.07495.x">http://dx.doi.org/10.1111/j.1610-0387.2010.07495.x</ext-link> 20718902 </plain></SENT>
</text></ref></ref-list></SecTag></back><floats-group><SecTag type="FIG"><fig id="F1" position="float"><label>Figure 1</label><caption><title>Violet wand (VW) plasma, left to right: assortment of electrodes, hand-held wand, and control unit</title></caption><graphic xlink:href="HIC-10-08-g-001"/></fig></SecTag><SecTag type="FIG"><fig id="F2" position="float"><label>Figure 2</label><caption><title>Electrical circuit and diagram of high-frequency treatment (skin touched by plasma spark filaments) </title><p><text><SENT sid="180" pm="."><plain>(from: Holzer W. </plain></SENT>
<SENT sid="181" pm="."><plain>Physikalische Medizin in Diagnostik und Therapie. </plain></SENT>
<SENT sid="182" pm="."><plain>5. und 6. erw. </plain></SENT>
<SENT sid="183" pm="."><plain>Aufl. </plain></SENT>
<SENT sid="184" pm="."><plain>Wien: Maudrich; 1947, XIV) </plain></SENT>
</text></p></caption><graphic xlink:href="HIC-10-08-g-002"/></fig></SecTag><SecTag type="FIG"><fig id="F3" position="float"><label>Figure 3</label><caption><title>Diameter of IA after plasma treatment of selected species a) CA, b) MSSA, c) SE, d) PA, and e) EC over 3–90s with DBD (A: large, 4.5 x 4.5 mm, B: small, 2 x 2 mm electrode), pulsed and non-pulsed (2 variants) APPJ (A, B, C), and VW</title></caption><graphic xlink:href="HIC-10-08-g-003"/></fig></SecTag></floats-group></article>
